ClinicalTrials.gg
CompletedNCT07748104VARIZONUpdated Aug 5, 2026

Zonulin Levels in Varicocele Patients

An observational study in Varicocele, Male Infertility and Zonulin, sponsored by Süleyman Tümer Çalışkan. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by Süleyman Tümer Çalışkan · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
119
Ages
18 Years to 50 Years
Sex
Male
01

Study summary

This prospective cross-sectional observational study was designed to evaluate serum and seminal plasma zonulin levels in infertile men with clinically diagnosed varicocele and compare them with those in infertile men without varicocele. The study also aimed to investigate the association between zonulin concentrations and conventional semen parameters.

A total of 119 men evaluated for infertility between December 2022 and May 2023 were included. Participants were classified into two groups according to the presence or absence of clinically diagnosed varicocele. Serum and seminal plasma zonulin concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Conventional semen parameters, including semen volume, sperm concentration, total sperm count, progressive motility, total motility, and normal sperm morphology, were evaluated and compared between the study groups.

Read the detailed description

Varicocele is one of the most common causes of male infertility and is associated with impaired spermatogenesis through multiple mechanisms, including oxidative stress, inflammation, and disruption of testicular microcirculation. Zonulin, a physiological regulator of epithelial tight junctions, has been proposed as a biomarker of increased intestinal permeability and systemic inflammation. However, the relationship between serum and seminal plasma zonulin levels and varicocele in infertile men has not been fully investigated.

This prospective observational study was designed to evaluate serum and seminal plasma zonulin levels in infertile men with clinically diagnosed varicocele and compare them with those in infertile men without varicocele. The study was also designed to examine the association between zonulin concentrations and conventional semen parameters, including semen volume, sperm concentration, total sperm count, progressive motility, total motility, and normal sperm morphology.

A total of 119 infertile men presenting to the Urology outpatient clinic between December 2022 and May 2023 were enrolled. Participants were assigned to groups according to the presence or absence of clinically diagnosed varicocele. Patients with systemic diseases, active infections, tobacco or cannabis use, use of medications known to affect semen parameters, abnormal body mass index, or evidence of genital tract infection were excluded. Serum and seminal plasma samples were collected on the day of semen analysis, and zonulin concentrations were measured using enzyme-linked immunosorbent assay (ELISA).

The primary objective was to compare serum and seminal plasma zonulin levels between infertile men with and without varicocele. Secondary objectives were to evaluate the association between zonulin concentrations and conventional semen parameters.

02

Conditions studied

  • Varicocele
  • Male Infertility
  • Zonulin

Keywords

  • Zonulin
  • Varicocele
  • Male infertility
03

In context

Varicocele

53 studies on the registry are indexed under Varicocele; 15 are open to participants now.

This study's enrollment of 119 is close to the median of 119 across 17 observational studies indexed under Varicocele.

Browse Varicocele studies →

Lead sponsor

This is the only study on the registry with Süleyman Tümer Çalışkan as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who had presented for infertility assessment were included in the study. Participants were divided into two groups: men with varicocele-related infertility and men with infertility without varicocele

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male patients aged 18 to 50 years.
  • Infertility requiring semen analysis.
  • No history of systemic disease.
  • Non-smokers and non-cannabis users.
  • No use of medications that could affect semen parameters within the previous 3 months.
  • (BMI) between 20 and 30 kg/m².

Exclusion criteria

Exclusion Criteria:

  • Presence of any chronic systemic disease.
  • Signs or symptoms of active infection.
  • Tobacco smoking or cannabis use.
  • Illicit drug use.
  • Use of medications that could affect semen parameters within the previous 3 months.
  • Clinical findings suggestive of prostatitis or urethritis (elevated white blood cell count on semen analysis).
  • (BMI) \<20 kg/m² or >30 kg/m².
  • Leukocyte concentration >1 × 10⁶ cells/mL in semen, indicative of a possible genital tract infection.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
119 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Control

    infertile men without varicocele

  • Varicocele

    infertile men with varicocele

06

What researchers measure

Primary outcomes

  1. Serum and Seminal Zonulin Levels

    Assessment and comparison of serum and seminal zonulin concentrations in infertile men with varicocele and infertile men without varicocele.

    Time frame: 1 day

  2. Comparison of Semen Parameters Between Groups

    Assessment and comparison of semen parameters between infertile men with varicocele and infertile men without varicocele

    Time frame: 1 day

07

Study locations

1 site
  • Gazi State Hospital
    Samsun, İlkadım, Turkey (Türkiye)
08

References and documents

Publications

  • Kaltsas A, Zikopoulos A, Markou E, Zachariou A, Stavropoulos M, Kratiras Z, Symeonidis EN, Dimitriadis F, Sofikitis N, Chrisofos M. Proteomics and Metabolomics in Varicocele-Associated Male Infertility: Advancing Precision Diagnostics and Therapy. J Clin Med. 2024 Dec 4;13(23):7390. doi: 10.3390/jcm13237390. PubMed 39685846 ↗
  • Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernandez-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One. 2012;7(5):e37160. doi: 10.1371/journal.pone.0037160. Epub 2012 May 18. PubMed 22629362 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared due to privacy and confidentiality concerns. Data access is restricted to the study investigators in accordance with institutional regulations.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07748104
Lead sponsor
Süleyman Tümer Çalışkan
Collaborators
Samsun University, Ondokuz Mayıs University
Responsible party
Süleyman Tümer Çalışkan (Specialist, Gazi State Hospital) — Sponsor-investigator
First posted
Aug 5, 2026
Start date
Dec 1, 2022
Primary completion
May 31, 2023
Completion
May 31, 2023
Last update
Aug 5, 2026

Study contacts

Süleyman T Çalışkan
principal investigator · Gazi State Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion